Morphometry demonstrates loss of cortical thickness in cerebral microangiopathy

被引:26
作者
Preul, C
Lohmann, G
Hund-Georgiadis, M
Guthke, T
von Cramon, DY
机构
[1] Max Planck Inst Human Cognit & Brain Sci, D-04103 Leipzig, Germany
[2] Univ Hosp Leipzig, Day Care Clin Cognit Neurol, Leipzig, Germany
关键词
MR-morphometry; cerebral microangiopathy; cortical thickness;
D O I
10.1007/s00415-005-0671-9
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective To evaluate the role of MR morphometry in the characterization of cerebral microangiopathy (CMA) in relation to clinical and neuropsychological impairment. Subjects and Methods 3D MR images of 27 patients and 27 age-matched controls were morphometrically analysed for regional thickness. The normalized values were related to the patients' clinical and neuropsychological scores. The patients were categorised according to the amount of structural MR signal changes. A ventricle index reflecting internal atrophy was related to MR morphology and cortical thickness as an indicator for external atrophy. Results Cortical thickness was significantly reduced in the patients group (3.03 mm +/- 0.26 vs. 3.22 mm +/- 0.13 in controls, p = 0.001). The severest loss of cortical thickness occurred in severe CMA. Internal and external atrophy evolved in parallel and both showed a significant relationship with structural MR-abnormalities ( p< 0.05; r= - 0.7; r= 0.67; r= - 0.74, respectively). Neuropsychological performance correlated strongly with the loss of cortical thickness. Conclusions Cortical thickness was identified as the most sensitive parameter to characterize CMA. A strong correlation was found of morphometric parameters to the severity of CMA based on a score derived from T2-weighted MRI. The degree of cortical atrophy was directly related to the degree of neuropsychological impairment. Our findings suggest that the cortical thickness is a valid marker in the structural and clinical characterization of CMA.
引用
收藏
页码:441 / 447
页数:7
相关论文
共 49 条
[1]   Voxel-based morphometry - The methods [J].
Ashburner, J ;
Friston, KJ .
NEUROIMAGE, 2000, 11 (06) :805-821
[2]   Imaging of white matter lesions [J].
Barkhof, F ;
Scheltens, P .
CEREBROVASCULAR DISEASES, 2002, 13 :21-30
[3]   Deformation-based surface morphometry applied to gray matter deformation [J].
Chung, MK ;
Worsley, KJ ;
Robbins, S ;
Paus, T ;
Taylor, J ;
Giedd, JN ;
Rapoport, JL ;
Evans, AC .
NEUROIMAGE, 2003, 18 (02) :198-213
[4]   From neuronal and vascular impairment to dementia [J].
De Deyn, PP ;
Goeman, J ;
Engelborghs, S ;
Hauben, U ;
D'Hooge, R ;
Baro, F ;
Pickut, BA .
PHARMACOPSYCHIATRY, 1999, 32 :17-24
[5]  
DELIS DC, 1987, CALIFORNIA VERBAL LE
[6]   Cognition and white matter lesions [J].
Desmond, DW .
CEREBROVASCULAR DISEASES, 2002, 13 :53-57
[7]  
Double KL, 1996, NEUROBIOL AGING, V17, P513
[8]   Effects of subcortical ischemic vascular dementia and AD on entorhinal cortex and hippocampus [J].
Du, AT ;
Schuff, N ;
Laakso, MP ;
Zhu, XP ;
Jagust, WJ ;
Yaffe, K ;
Kramer, JH ;
Miller, BL ;
Reed, BR ;
Norman, D ;
Chui, HC ;
Weiner, MW .
NEUROLOGY, 2002, 58 (11) :1635-1641
[9]   Neuropathology of white matter lesions in vascular cognitive impairment [J].
Englund, E .
CEREBROVASCULAR DISEASES, 2002, 13 :11-15
[10]   RETHINKING VASCULAR DEMENTIA [J].
ERKINJUNTTI, T ;
HACHINSKI, VC .
CEREBROVASCULAR DISEASES, 1993, 3 (01) :3-23